NFE2L2 and breast cancer: Studies have shown that chemotherapy-resistant breast cancer cells exhibit increased Nrf2 stabilization, leading to higher antioxidant enzyme levels and reduced reactive oxygen species (ROS), which supports the CSC phenotype [290].